Explore a comprehensive lecture on managing Inflammatory Bowel Disease (IBD) with precision, delivered by Dr. Marla Dubinsky at the 9th Annual UCLA-Mellinkoff Gastroenterology and Hepatology Symposium. Delve into crucial topics such as early intervention strategies, risk assessment of therapies, and diagnostic challenges in Crohn's disease. Examine the importance of timely biological treatments and real-world prescription practices. Gain insights into predicting prognosis using tools like CDPath and Target. Analyze the STRIDE targets and their updates, focusing on quality of life improvements and biomarker utilization. Investigate disease-modifying approaches, therapeutic drug monitoring, and proactive dose optimization for both induction and maintenance phases. Learn about personalizing pharmacokinetics and explore the future of prognostic markers in IBD management.
Managing IBD with Precision - Marla Dubinsky, MD - UCLA-Mellinkoff GI & Hep Symposium 2021
University of California, Los Angeles via YouTube
Overview
Syllabus
Intro
Early Intervention
Risk of Therapies
Crohns Disease
Diagnostic Delay
Early Intervention with biologics
Real World Prescriptions
Predicting Prognosis
CDPath
Target
Summary
stride targets
stride 2 update
quality of life
biomarkers
outcomes
disease modifying
therapeutic drug monitoring
proactive dose escalation
proactive dose optimization
induction
maintenance efficacy
maintenance arm
personalizing pk
future of pk
prognostic markers
Taught by
UCLA Health
